http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14746726

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 1380
issn 1535-7163
1538-8514
issueIdentifier 6
pageRange 1373-1380
publicationName Molecular Cancer Therapeutics
startingPage 1373
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_100f38bfde135d17378af58ddaf13fb0
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c299d74bcc343e1d33b7ac2ea0ee54ec
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b9bc16d5a5f286ba726cb5fca5f73e2a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c95db7fa4d2ef7237448e9571511b65e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3d747b8e14e4f74034b3b5bdbb6f8625
bibliographicCitation Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun;11(6):1373–80. PMID: 22572813; PMCID: PMC3856684.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6908e63c009ad949e8bec27d152cf64e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8a61f4f4d5b2e0a23ac18ade5fe3a2d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ee7286c2c677d3e506aeca736eb8641
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6137389ded22256ea3532644d84c872e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_922b96aac910bd7ad3cd202017e82713
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8676937027196735baea7fed145f11d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_061e4d95456d65dd36868b84b88b28a4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae63603cf0c0f8087f1c81441f8f8dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_553b4c94f2b89fbe2f3fefb93c29e63d
date 2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3856684
https://pubmed.ncbi.nlm.nih.gov/22572813
https://doi.org/10.1158/1535-7163.mct-12-0041
isPartOf https://portal.issn.org/resource/ISSN/1538-8514
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
https://portal.issn.org/resource/ISSN/1535-7163
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation
discusses http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0006004
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D013964Q000378
http://id.nlm.nih.gov/mesh/D013964Q000628
http://id.nlm.nih.gov/mesh/D003847Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D065646
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D014407
http://id.nlm.nih.gov/mesh/D059248
http://id.nlm.nih.gov/mesh/D003847Q000494
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D006019
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c50845b337a3c11fa194521642a3ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11482
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_606d6234a2cf2e2d52b0ade7ed869ca5

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129518404

Total number of triples: 64.